We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ICM

News List

Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier prnasia
June 08, 2021
Onward Therapeutics (Onward) and Institut du Cancer de Montpellier (ICM) announced today the execution of an exclusive collaboration and worldwide option and license agreement based on a research program in onco-metabolism being conducted by ICM ...
CONTINUUS Awarded $69.3M DoD Grant contractpharma
January 25, 2021
CONTINUUS Pharmaceuticals Inc. received a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including COVID-19.